https://www.selleckchem.com/pr....oducts/lotiglipron.h
This is the first to report follow up at 1 year. Both MRI and exam showed no evidence of recurrent disease at one year follow up. This report aims to further the understanding of Secretory Carcinoma tumours in the sinuses. Our report could be used to further understand diagnostic criteria for Secretory Carcinoma in the sinuses as well as treatment outcomes for surgical resection without adjuvant treatment. Both MRI and exam showed no evidence of recurrent disease at one year follow up. This report aims to further the understanding o